All Type of News
Is MOHW still reviewing pending issues related to the drug serial number system for 2 years?
The drug serial number obligation, which will be enforced on pharmaceutical distribution companies, has come closer in about 3 months, but the government has still not been able to give clear answers on the key pendin...
Listed pharmas took 69 days for inventory asset rotation period
It was analyzed it took 69 days – it was increased by 3.7 days compared to the year before – on average to clear out the stock in 2016.
According to the Yakup Shinmoon’s(www.yakup.com) analysis result of KOSPI and KO...
Only 48.7% of young adults having sexual experience use birth control
It was observed more than a half of 10 young adults who have sexual experience practice no birth control at all.
The Ob/Gyn Professor Dong-Yoon Lee’ research team at Samsung Medical Center revealed the analysis resul...
CGBio starts first clinical trial for next-generation stent for coronary artery
CGBio(CEO Hyun-Seung Yoo) announced after the Ministry of Food and Drug Safety(MOHW) approved the clinical trial plan of drug-eluting stent for coronary artery, Professor Hyo-Soo Kim’s research team at Seoul National ...
Revision bill for the National Health Insurance Contribution System passed Bill Examination Subcommittee
After the tough time, the revision bill for the National Health Insurance Contribution System passed the Bill Examination Subcommittee at the National Assembly Health & Welfare Committee.
The revision bill for the Na...
‘Telemedicine’ went in vain at Bill Examination Subcommittee
Telemedicine, which has drawn attention as introduced at the Bill Examination Subcommittee, could not be discussed again.
The National Assembly Health & Welfare Committee introduced the ‘Amendment to the Medical Law’...
5 pharmas including Yuhan Corporation spent KRW 30 billion advertising expenses last year
A company which spent the most into advertising last year was Yuhan Corporation with KRW 51.3 billion, and there were the total 4 pharmaceutical companies that invested more than KRW 30 billion advertising expenses in...
Kwang Dong made registration of patent with Kyungokko in Japan for prevention and treatment of male infertility
Kwang Dong Pharmaceutical(CEO Sung-Won Choi) announced on the 21st that Kyungokko KwangDong, which has been exported to Japan, registered a patent(No. JP6063499, expiring on Feb 27 2035) at the Japan Patent Office as ...
Distribution companies burden additional KRW 186.9 billion for real-time reporting system
It was observed pharmaceutical distribution companies will need to pay additional expenses more than KRW 180 billion to make reports for drug serial numbers in real-time, which is scheduled to be enforced on July.
Th...
KPA raises one voice, ‘management over expansion for household products’
Saying “For the national health, we can never accept the ‘Expansion of Emergency Household Drugs’ sold in convenient stores,” Korean Pharmaceutical Association(KPA) Policy Director Bong-Yoon Kang made a strong critici...
